Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 4 of 123)
- Relevance
  Sort by

Hepatitis B Infection Treatment Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4504EUR$4,949USD£3,826GBP

HIV Drugs Market By Medication Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

 Report
November 2023
35 Pages
Global

From

€2351EUR$2,583USD£1,997GBP

€3359EUR$3,690USD£2,853GBP

Bladder Cancer Therapeutics - Global Strategic Business Report

 Report
April 2025
283 Pages
Global

From

€5324EUR$5,850USD£4,522GBP

Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems

 Report
June 2023
174 Pages
Global

From

€4232EUR$4,650USD£3,595GBP

Bioavailability Enhancement Technologies and Services Market by Drug Class, BCS Classification, Bioavailability Enhancement Approach, Dosage Form and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
November 2022
270 Pages
Global

From

€5369EUR$5,899USD£4,560GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Skin Cancer Drugs Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4087EUR$4,490USD£3,471GBP

Brain Hemorrhage - Pipeline Insight, 2025

 Clinical Trials
April 2025
75 Pages
Global

From

€1365EUR$1,500USD£1,160GBP

Endometrial Cancer Treatment Market by Treatment, Grade, End-User - Global Forecast 2025-2030

 Report
October 2024
181 Pages
Global

From

€3227EUR$3,545USD£2,741GBP

€3585EUR$3,939USD£3,045GBP

Non-Melanoma Skin Cancer Treatment Market Report by Treatment Type, Indication, End Use, and Region 2024-2032

 Report
August 2024
144 Pages
Global

From

€2730EUR$2,999USD£2,318GBP

Olanzapine Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4087EUR$4,490USD£3,471GBP

Skin Cancer Diagnostics and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
110 Pages
Global

From

€4323EUR$4,750USD£3,672GBP

Ankylosing Spondylitis Market by Drug, Type of Molecule, Mechanism Of Action, Route Of Administration, Dosage Forms, End User - Global Forecast 2025-2030

 Report
October 2024
195 Pages
Global

From

€3227EUR$3,545USD£2,741GBP

€3585EUR$3,939USD£3,045GBP

Mitomycin C Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
April 2023
103 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Global Hepatitis Therapeutics Market 2030 by Hepatitis Type, Drug Class, Drug Type, End-user and Distribution Channel and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints

 Report
August 2023
180 Pages
Global

From

€3413EUR$3,750USD£2,899GBP

United States Skin Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
90 Pages
United States

From

€3186EUR$3,500USD£2,706GBP

Kidney Cancer Drugs - Global Strategic Business Report

 Report
April 2025
148 Pages
Global

From

€5324EUR$5,850USD£4,522GBP

Urinary Tract Infection Market by Clinical Indication, Treatment, End User - Global Forecast 2025-2030

 Report
October 2024
194 Pages
Global

From

€3227EUR$3,545USD£2,741GBP

€3585EUR$3,939USD£3,045GBP

Hepatitis C Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
91 Pages
Global

From

€3500EUR$4,119USD£3,077GBP

Diabetic Nephropathy Treatment Market by Treatment Type, End-User - Global Forecast 2025-2030

 Report
October 2024
181 Pages
Global

From

€3227EUR$3,545USD£2,741GBP

€3585EUR$3,939USD£3,045GBP

U.S. Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing: Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030

 Report
September 2024
116 Pages
United States

From

€2271EUR$2,495USD£1,929GBP

2,452 Results (Page 4 of 123)
- 1
- 2
- 3
- 4
- 5
- 6

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.